Dr William Whiteley
Senior Clinical Fellow
William Whiteley is a Scottish Senior Clinical Fellow (funded by CSO) in the Centre for Clinical Brain Sciences, University of Edinburgh.
He is also Senior Clinical Fellow in the Nuffield Department of Population Health, University of Oxford; an International Fellow at the Population Health Research Institute, University of McMaster (Canada); and a consultant neurologist in NHS Lothian, working with patients with stroke and dementia.
His work seeks to elucidate the mechanisms for prevention of disability due to stroke and dementia through the design, delivery and analysis of epidemiological studies and clinical trials. Of particular interest are: the contribution of vascular risk factors to dementia; the very long term follow-up of randomised trials; and the better use of large electronic health record datasets for more efficient clinical trials and cohort studies.
He has founded and run the Edinburgh Stroke Winter School. He has been supported by personal fellowships from the UK MRC (Clinician Scientist fellowship 2010-2015), the Chief Scientist’s Office (2006-2009, 2018-2025), and his work by the Alzheimer's Society, the Stroke Association and Chest, Heart and Stroke Scotland.
Current research interests:
- Contribution of known vascular risk factors to dementia
- Diagnosis and treatment of minor and transient neurological attacks
- Development of novel methods for large scale trials with electronic health records
Clinical Diagnosis and Magnetic Resonance Imaging in Patients With Transient and Minor Neurological Symptoms: A Prospective Cohort Study.
Whiteley WN. et al, (2022), Stroke, 53, 3419 - 3428
Automated clinical coding: what, why, and where we are?
Dong H. et al, (2022), NPJ Digit Med, 5
18F-NaF PET/MRI for Detection of Carotid Atheroma in Acute Neurovascular Syndrome.
Kaczynski J. et al, (2022), Radiology, 305, 137 - 148
Association of COVID-19 With Major Arterial and Venous Thrombotic Diseases: A Population-Wide Cohort Study of 48 Million Adults in England and Wales.
Knight R. et al, (2022), Circulation, 146, 892 - 906
Systolic blood pressure variability is a major risk factor for renal outcomes in hypertensive patients: Evidence from the 20-year follow-up of the Anglo-Scandinavian Cardiac Outcomes Trial (ASCOT)
Rostamian S. et al, (2022), JOURNAL OF HUMAN HYPERTENSION, 36, 21 - 21